Published in

Elsevier, The Lancet Diabetes and Endocrinology, 8(7), p. 618-628, 2019

DOI: 10.1016/s2213-8587(19)30158-5

Links

Tools

Export citation

Search in Google Scholar

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Journal article published in 2019 by Kausik K. Ray, Michael Szarek, Helen M. Colhoun, Deepak L. Bhatt, Marie Baccara-Dinet, Vera A. Bittner, Rafael Diaz, Andrzej J. Budaj, Shaun G. Goodman, Robert A. Harrington, Corinne Hanotin, J. Wouter Jukema, Angèle Moryusef, Renato D. Lopes, Virginie Loizeau and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO